Cargando…

FABP3 Deficiency Exacerbates Metabolic Derangement in Cardiac Hypertrophy and Heart Failure via PPARα Pathway

Background: Cardiac hypertrophy was accompanied by various cardiovascular diseases (CVDs), and due to the high global incidence and mortality of CVDs, it has become increasingly critical to characterize the pathogenesis of cardiac hypertrophy. We aimed to determine the metabolic roles of fatty acid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhuang, Lingfang, Mao, Ye, Liu, Zizhu, Li, Chenni, Jin, Qi, Lu, Lin, Tao, Rong, Yan, Xiaoxiang, Chen, Kang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387950/ https://www.ncbi.nlm.nih.gov/pubmed/34458345 http://dx.doi.org/10.3389/fcvm.2021.722908

Ejemplares similares

Downregulation of PTEN Promotes Autophagy via Concurrent Reduction in Apoptosis in Cardiac Hypertrophy in PPAR α(−/−) Mice
por: Kumari, Ritu, et al.
Publicado: (2022)

Derangement of cardiac energy metabolism is acutely exacerbated during exercise in hypertrophic cardiomyopathy, independent of hypertrophy or late gadolinium burden
por: Dass, Sairia, et al.
Publicado: (2012)

ACSM5 inhibits ligamentum flavum hypertrophy by regulating lipid accumulation mediated by FABP4/PPAR signaling pathway
por: Cao, Yanlin, et al.
Publicado: (2023)

Comprehensive Integration of Single-Cell Transcriptional Profiling Reveals the Heterogeneities of Non-cardiomyocytes in Healthy and Ischemic Hearts
por: Zhuang, Lingfang, et al.
Publicado: (2020)

Angiogenic Endothelial Cell Signaling in Cardiac Hypertrophy and Heart Failure
por: Gogiraju, Rajinikanth, et al.
Publicado: (2019)

Roles of histone acetylation sites in cardiac hypertrophy and heart failure
por: Funamoto, Masafumi, et al.
Publicado: (2023)

Unraveling the Metabolic Derangements Occurring in Non-infarcted Areas of Pig Hearts With Chronic Heart Failure
por: Correia, Cláudia, et al.
Publicado: (2021)

PPARγ Transcription Deficiency Exacerbates High-Fat Diet-Induced Adipocyte Hypertrophy and Insulin Resistance in Mice
por: Guo, Fusheng, et al.
Publicado: (2020)

Iron Deficiency and Deranged Myocardial Energetics in Heart Failure
por: Tkaczyszyn, Michał, et al.
Publicado: (2022)

Impact of polyphenols on heart failure and cardiac hypertrophy: clinical effects and molecular mechanisms
por: Hedayati, Neda, et al.
Publicado: (2023)

Trimethyllysine, a trimethylamine N-oxide precursor, predicts the presence, severity, and prognosis of heart failure
por: Zong, Xiao, et al.
Publicado: (2022)

Protective Effects of Thyroid Hormone Deprivation on Progression of Maladaptive Cardiac Hypertrophy and Heart Failure
por: Kerp, Helena, et al.
Publicado: (2021)

The Interaction of FABP with Kapα
por: Amber-Vitos, Ortal, et al.
Publicado: (2015)

Inhalation of diesel exhaust does not exacerbate cardiac hypertrophy or heart failure in two mouse models of cardiac hypertrophy
por: Liu, Yonggang, et al.
Publicado: (2013)

Effects of EPA supplementation on plasma fatty acids composition in hypertriglyceridemic subjects with FABP2 and PPARα genotypes
por: Pishva, Hamideh, et al.
Publicado: (2012)

Dapagliflozin Mediates Plin5/PPARα Signaling Axis to Attenuate Cardiac Hypertrophy
por: Yu, Jing, et al.
Publicado: (2021)

Cardiac ISL1-Interacting Protein, a Cardioprotective Factor, Inhibits the Transition From Cardiac Hypertrophy to Heart Failure
por: Yan, Youchen, et al.
Publicado: (2022)

Hispidulin Attenuates Cardiac Hypertrophy by Improving Mitochondrial Dysfunction
por: Wang, Yan, et al.
Publicado: (2020)

PPAR α contributes to protection against metabolic and inflammatory derangements associated with acute kidney injury in experimental sepsis
por: Iwaki, Takuma, et al.
Publicado: (2019)

Toll-like receptors in cardiac hypertrophy
por: Zhang, Yanan, et al.
Publicado: (2023)

Depdc5 deficiency exacerbates alcohol-induced hepatic steatosis via suppression of PPARα pathway
por: Xu, Lin, et al.
Publicado: (2021)

Cardiomyocyte Overexpression of FABP4 Aggravates Pressure Overload-Induced Heart Hypertrophy
por: Zhang, Ji, et al.
Publicado: (2016)

HMGB1 Is Involved in the Protective Effect of the PPARα Agonist Fenofibrate against Cardiac Hypertrophy
por: Jia, Zhankui, et al.
Publicado: (2014)

Commentary: Dapagliflozin Mediates Plin5/PPARα Signaling Axis to Attenuate Cardiac Hypertrophy
por: Liu, Zengying, et al.
Publicado: (2022)

Expression and enhancement of FABP4 in septoclasts of the growth plate in FABP5-deficient mouse tibiae
por: Bando, Yasuhiko, et al.
Publicado: (2021)

A high-throughput drug screening identifies luteolin as a therapeutic candidate for pathological cardiac hypertrophy and heart failure
por: Wang, Zhenya, et al.
Publicado: (2023)

Mitochondria in Pathological Cardiac Hypertrophy Research and Therapy
por: Yang, Dan, et al.
Publicado: (2022)

Shugan Xiaozhi Decoction Attenuates Nonalcoholic Steatohepatitis by Enhancing PPARα and L-FABP Expressions in High-Fat-Fed Rats
por: Xing, Yu-feng, et al.
Publicado: (2016)

Downregulation of PPARα mediates FABP1 expression, contributing to IgA nephropathy by stimulating ferroptosis in human mesangial cells
por: Wu, Jingkui, et al.
Publicado: (2022)

The Potential Therapeutic Role of Celastrol in Patients With Heart Failure With Preserved Ejection Fraction
por: Ajmal, Maryam, et al.
Publicado: (2021)

Loss of Akap1 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy and Heart Failure
por: Schiattarella, Gabriele G., et al.
Publicado: (2018)

miR-208a in Cardiac Hypertrophy and Remodeling
por: Huang, Xing-Huai, et al.
Publicado: (2021)

Role of CyPA in cardiac hypertrophy and remodeling
por: Cao, Mengfei, et al.
Publicado: (2019)

Corin deficiency impairs cardiac function in mouse models of heart failure
por: Niu, Yayan, et al.
Publicado: (2023)

Mechanism of histone deacetylases in cardiac hypertrophy and its therapeutic inhibitors
por: Han, Yu, et al.
Publicado: (2022)

Correlation Between Liver Stiffness and Diastolic Function, Left Ventricular Hypertrophy, and Right Cardiac Function in Patients With Ejection Fraction Preserved Heart Failure
por: Zhang, Junyi, et al.
Publicado: (2021)

Effect of Berberine on PPARα/NO Activation in High Glucose- and Insulin-Induced Cardiomyocyte Hypertrophy
por: Wang, Mingfeng, et al.
Publicado: (2013)

Doxorubicin resistance in breast cancer is mediated via the activation of FABP5/PPARγ and CaMKII signaling pathway
por: Chen, Nan-Nan, et al.
Publicado: (2023)

RNAi-mediated germline knockdown of FABP4 increases body weight but does not improve the deranged nutrient metabolism of diet-induced obese mice
por: Yang, R, et al.
Publicado: (2011)

Treatise on Mental Derangement, and on Hospitals for the Deranged
Publicado: (1829)

Cannot write session to /tmp/vufind_sessions/sess_rmssld2pq6722bgolal9fnsb6l